Modeling the effectiveness of olfactory testing to limit SARS-2-CoV transmission
View ORCID ProfileDaniel B. Larremore, View ORCID ProfileDerek Toomre, View ORCID ProfileRoy Parker
doi: https://doi.org/10.1101/2020.11.30.20241174
Daniel B. Larremore
1Department of Computer Science, University of Colorado Boulder
2BioFrontiers Institute, University of Colorado Boulder
Derek Toomre
3Department of Cell Biology, Yale University School of Medicine
Roy Parker
2BioFrontiers Institute, University of Colorado Boulder
4Department of Biochemistry, University of Colorado Boulder
5Howard Hughes Medical Institute
Data Availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials, and open-source code is available at the accompanying github.
Posted December 02, 2020.
Modeling the effectiveness of olfactory testing to limit SARS-2-CoV transmission
Daniel B. Larremore, Derek Toomre, Roy Parker
medRxiv 2020.11.30.20241174; doi: https://doi.org/10.1101/2020.11.30.20241174
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12626)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4487)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2870)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4254)
- Nursing (228)
- Nutrition (622)
- Oncology (2229)
- Ophthalmology (635)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6834)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)